SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
SeaStar Medical Holding Corporation (ICU)
Company Research
Source: GlobeNewswire
U.S. total addressable market for five initial indications is $25 to $33 billion REMINDER: Business Update Conference Call begins at 4:30 p.m. Eastern time today DENVER , Dec. 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, estimates a U.S. total addressable market for its proprietary, patented Selective Cytopheretic Device (SCD) in five clinical indications, subject to U.S. Food & Drug Administration (FDA) approvals, of $25 to $33 billion. The following chart summarizes ranges of the adult SCD total addressable market and estimated clinical trial costs, by indication: Clinical IndicationAnnual U.S. Patient Population1Total Addressable U.S. Market$ in millions2Clinical Trial Costs$ in millionsAdult Acute Kidney Injury (AKI)3210,0004,700 – 6,300154Cardiorenal Syndrome with no LVAD5580,00013,100 -17,4005Adult Acu
Show less
Read more
Impact Snapshot
Event Time:
ICU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICU alerts
High impacting SeaStar Medical Holding Corporation news events
Weekly update
A roundup of the hottest topics
ICU
News
- SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal TrialGlobeNewswire
- SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating SeaStar Medical Holding Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- SeaStar Medical to Hold Business Update Conference Call on December 11, 2024GlobeNewswire
- SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal TrialGlobeNewswire
- SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024GlobeNewswire
ICU
Sec Filings
- 12/19/24 - Form 8-K
- 12/3/24 - Form 3
- 12/3/24 - Form 3
- ICU's page on the SEC website